ULTI.OL Net Margin

As of 2025-05-17, the Net Margin of Ultimovacs ASA (ULTI.OL) is -245.4%.

Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

ULTI.OL Net Margin - Historical Value

Date	Value
2024-12-31	-245.4%
2023-12-31	-
2022-12-31	-
2021-12-31	-
2020-12-31	-
2019-12-31	-
2018-12-31	-
2017-12-31	-
2016-12-31	-
2015-12-31	-245.4%

ULTI.OL Net Margin - Peers Comparison

Ticker	Name	Value
AZT.OL	Arcticzymes Technologies ASA	7.3%
BGBIO.OL	Bergenbio ASA	-16424.8%
EXTX.OL	Exact Therapeutics AS	-16466.7%
HBC.OL	Hofseth Biocare ASA	-47.9%
LYTIX.OL	Lytix Biopharma AS	-846.6%
NANOV.OL	Nordic Nanovector ASA	-97289.4%
PCIB.OL	PCI Biotech Holding ASA	-243.8%
TRVX.OL	Targovax ASA	-4328.1%
VACC.OL	Vaccibody AS	69.7%